Retatrutide (5mg–60mg)
Description & mechanism
Retatrutide is a synthetic peptide and triple agonist of the GLP-1, GIP, and glucagon receptors, engineered to probe combined incretin and glucagon-receptor activity. It is used in research to study energy metabolism, glucose homeostasis, and adipose signalling in experimental models.
Applications in research
- Multi-receptor (GLP-1/GIP/glucagon) activation and selectivity profiling
- Glucose regulation and insulin-secretion studies in vitro
- Metabolic and energy-expenditure signalling in preclinical models
Specifications
Handling, reconstitution & storage
Reconstitute the lyophilized solid in sterile water or bacteriostatic diluent to the desired working concentration; mix by gentle inversion and avoid vigorous agitation or repeated freeze-thaw. Sterile-filter (0.22 µm) if aseptic use is required, aliquot into single-use volumes, and store reconstituted material frozen at -20 °C.
Precautions & notes
For in-vitro research and laboratory use only. Bodily introduction of any kind into humans or animals is strictly forbidden. Handle as a bioactive substance using appropriate PPE and consult the safety data sheet. Note: retatrutide is an investigational peptide with no approved human use.
References
This product is furnished for in-vitro research and laboratory use only. Bodily introduction of any kind into humans or animals is strictly forbidden.